The global digital therapeutics market is witnessing considerable growth due to increasing prevalence of chronic diseases and lifestyle associated diseases, growing geriatric population, need to control healthcare cost, and technological advancement. Moreover, increasing focus on preventive healthcare and increase in venture capital investment are supporting the growth of the market. The benefits of digital therapeutics such as improved drug adherence, ability to induce behavioral changes and patient convenience across the globe is also driving the growth of the market. Based on type of application, the market for preventive application segment is expected to grow at the faster rate during the forecast period, due to increasing government initiatives to increase preventive healthcare.
Explore Report at: https://www.psmarketresearch.com/market-analysis/digital-therapeutics-market
Geriatric population has weakened body functions, impaired blood circulation and are more susceptible to chronic diseases. As per the United Nations Department of Economic and Social Affairs (UN-DESA) report on the global aging population, the population of people aged 60 years or above is growing with high rate. In 2013, the global percentage of people aged 60 or above was 11.7% and it is expected to reach 21.1% by the end of 2050. Further, the number of people aged 60 years and above is expected to reach approximately 437 million in China, 324 million in India, 107 million in the U.S. and 58 million in Brazil by 2050.
Browse For Table of Content at: https://www.psmarketresearch.com/market-analysis/digital-therapeutics-market/toc-sample
The key players operating in the global market are Proteus Digital Health Inc., Omada Health Inc., Welldoc Inc., Livongo Health, Noom Inc., Propeller Health, Canary Health Inc., and Mango Health Inc.